These findings indicate that immunotherapy can promote the infiltration of CD4+cells, CD8+ T cells, B cells and NK cells, and reduce the number of M2 macrophages, which in turn reduces immunosuppression and exerts anti-tumor effects. The gene discussed is CD4; the disease is neoplasm.